Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
The opinions expressed here are strictly my own.
People who reenrolled in marketplace health care plans saved $43 per month on average by shopping and switching plans
Corinna Dan of the Office of HIV/AIDS and Infectious Disease Policy discusses updated guidelines for the treatment of chronic hepatitis B...
Cheryl Reitz confronts her beliefs about generics and discusses their use for hepatitis C treatment
This article highlights the importance of hepatitis C testing for all baby boomers.
An explanation of pan-genotypic drugs used to treat hepatitis C.
Here’s what’s in store this year for new hepatitis C therapies, as well as approvals for new uses of existing treatments.
After years of much neglect, there is hope on the horizon for U.S. Veterans with hepatitis C
While traveling in India, HepCBC board member and volunteer Cheryl Reitz, confronts her beliefs about generics, and shares her new-found kno...
Ron Valdiserri of the U.S. Department of Health and Human Services requests input from viral hepatitis stakeholders
Elizabeth Faraone, now cured of hepatitis C, discusses treatment and the power of advocacy
Ron Valdiserri of the U.S. Department of Health and Human Services reports on the recent Action Plan for the Prevention, Care, and Treatment...
This article discusses the connection between rheumatoid arthritis and hepatitis C virus infection, along with ways to manage it
An overview of clinical trials, the pluses and minuses of participating in a clinical study and information about how to find clinical trial...
A discussion of the price of Gilead's hepatitis C drugs and findings reported by the U.S. Senate Finance Committee
Here are the hepatitis treatment news stories with the most views this year.